Article

Highway to the danger zone? A cautionary account that GLP-1 receptor agonists may be too effective for unmonitored weight loss

2023-08-30

Abstract excerpt

<p>Glucagon-like peptide 1 (GLP-1) receptor agonists are revolutionizing obesity and type 2 diabetes treatment, delivering remarkable weight loss outcomes. These medications, leveraging the effects of the insulin-regulating hormone GLP-1 via actions on peripheral and central nervous system targets, have raised hopes with their bariatric surgery-rivaling results. However, questions remain about their long-term safe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9c9f4284-9a74-5cd0-8d23-1fc5cafdd335
DOI: 10.31234/osf.io/uxa78

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Highway to the danger zone? A cautionary account that GLP-1 receptor agonists may be too effective for unmonitored weight lossDOI 10.31234/osf.io/uxa78Read

From one-size-fits-all to phenotype-based pharmacotherapy: How far are we in obesity management?Semantic proximity Read

Clinical efficacy landscaping in genetic obesity: A meta-analysis in Prader Willi syndrome (PWS)Semantic proximity Read

Greater lean-body-mass decline with tirzepatide than semaglutide in routine care, revealed by body-composition digital phenotypingSemantic proximity Read

Obesity - an epidemic of the twenty-first century: an update for psychiatrists.Semantic proximity Read

Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan.Semantic proximity Read

Exploring the off-Label use of liraglutide in the treatment of obesity: a reviewSemantic proximity Read

Endogenous Incretin Insufficiency in Obesity: Etiological Defect or Metabolic Maladaptation?Semantic proximity Read

Greater lean-body-mass decline with tirzepatide than semaglutide in routine care, revealed by body-composition digital phenotypingSemantic proximity Read

Obstetrician-Gynecologists' Strategies for Patient Initiation and Maintenance of Antiobesity Treatment with Glucagon-Like Peptide-1 Receptor AgonistsSemantic proximity Read

A Brain Reward Circuit Inhibited By Next-Generation Weight Loss DrugsSemantic proximity Read

Incident Frailty and Mortality Risk with Significant Tirzepatide-Associated Weight Loss in Medicare-Age PatientsSemantic proximity Read

Treatment of obesity: should we target the individual or society?Semantic proximity Read